Anti-NG2 Purified
CAT:
270-11-199-C100
Size:
0.1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Anti-NG2 Purified
- Background: NG2 / chondroitin sulfate proteoglycan 4 is expressed on glial cell populations, but not on normal hepatopoietic cells. It is an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells, where it plays role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes, and supports signaling pathways important for tumor invasion and growth. NG2 also serves as an AML blast tumor marker associated with poor prognosis.
- Specifications: The mouse monoclonal antibody 7.1 recognizes an extracellular epitope of NG2, the melanoma-associated chondroitin sulfate proteoglycan 4 of Mw approximately 220-300 kDa.
- CAS Number: 9007-83-4
- Certification: RUO
- Host: Mouse
- Species Reactivity: Human
- Immunogen: Human bone marrow stromal cells infected with SV-40
- Target Antigen: NG2
- Isotype: IgG1
- Clone: 7.1
- Applications: Flow cytometry: Recommended dilution: 1-4 μg/mL.
- Validated Applications: FC, IP, WB, ICC
- Concentration: 1 mg/mL
- Format: Purified
- Buffer: Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
- References & Citations: *Cattaruzza S, Nicolosi PA, Braghetta P, Pazzaglia L, Benassi MS, Picci P, Lacrima K, Zanocco D, Rizzo E, Stallcup WB, Colombatti A, Perris R: NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion. J Mol Cell Biol. 2013 Jun5(3):176-93., URL: https://pubmed.ncbi.nlm.nih.gov/23559515/,*Girolamo F, Dallatomasina A, Rizzi M, Errede M, Wälchli T, Mucignat MT, Frei K, Roncali L, Perris R, Virgintino D: Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets. PLoS One. 2013 Dec 268(12):e84883., URL: http://www.ncbi.nlm.nih.gov/pubmed/24386429 Emeren,*Petrovici K, Graf M, Hecht K, Reif S, Pfister K, Schmetzer H: Use of NG2 (7.1) in AML as a tumor marker and its association with a poor prognosis. Cancer Genomics Proteomics. 2010 Jul-Aug7(4):173-80., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=petrovici+k+graf+m+hecht+k,
- Storage Conditions: Store at 2-8°C. Do not freeze.